DLA Piper represented BTG plc, a global specialist healthcare company, in its acquisition of Novate Medical Ltd., a medical device company focused on the prevention of pulmonary embolism in patients at high risk of blood clots.

BTG plans to launch Sentry, a device developed by Novate that is designed to prevent blood clots in the leg from traveling to the lungs in patients at risk of pulmonary embolism, in the second half of its current fiscal year.

The DLA Piper team was led by partners Kevin Grant (Short Hills), Andrew Phillips and Yunus Maka, and included associates James Petts and Laura Evans (all of Manchester, UK).

About DLA Piper (www.dlapiper.com)

DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. In certain jurisdictions, this information may be considered attorney advertising.